Pneumococcal capsules and their types: past, present, and future KA Geno, GL Gilbert, JY Song, IC Skovsted, KP Klugman, C Jones, ... Clinical microbiology reviews 28 (3), 871-899, 2015 | 810 | 2015 |
Characteristics of Hodgkin's lymphoma after infectious mononucleosis H Hjalgrim, J Askling, K Rostgaard, S Hamilton-Dutoit, M Frisch, JS Zhang, ... New England Journal of Medicine 349 (14), 1324-1332, 2003 | 536 | 2003 |
Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study ZB Harboe, RW Thomsen, A Riis, P Valentiner-Branth, JJ Christensen, ... PLoS medicine 6 (5), e1000081, 2009 | 376 | 2009 |
Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality ZB Harboe, T Dalby, DM Weinberger, T Benfield, K Mølbak, HC Slotved, ... Clinical Infectious Diseases 59 (8), 1066-1073, 2014 | 353 | 2014 |
Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades ZB Harboe, TL Benfield, P Valentiner-Branth, T Hjuler, L Lambertsen, ... Clinical Infectious Diseases 50 (3), 329-337, 2010 | 207 | 2010 |
In vivo cell-mediated immunity and vaccination response following prolonged, intense exercise. H Bruunsgaard, A Hartkopp, T Mohr, H Konradsen, I Heron, CH Mordhorst, ... Medicine and Science in Sports and Exercise 29 (9), 1176-1181, 1997 | 192 | 1997 |
Serotype-specific mortality from invasive Streptococcus pneumoniaedisease revisited P Martens, SW Worm, B Lundgren, HB Konradsen, T Benfield BMC infectious diseases 4, 1-7, 2004 | 183 | 2004 |
Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia J Törling, J Hedlund, HB Konradsen, Å Örtqvist Vaccine 22 (1), 96-103, 2003 | 181 | 2003 |
Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according to the focus of infection C Østergaard, HB Konradsen, S Samuelsson BMC infectious diseases 5, 1-11, 2005 | 177 | 2005 |
Invasive group A, B, C and G streptococcal infections in Denmark 1999–2002: epidemiological and clinical aspects K Ekelund, P Skinhøj, J Madsen, HB Konradsen Clinical Microbiology and Infection 11 (7), 569-576, 2005 | 165 | 2005 |
Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance HB Konradsen, MS Kaltoft Clinical and Vaccine Immunology 9 (2), 358-365, 2002 | 126 | 2002 |
Pneumococcal infections in splenectomized children are preventable HB Konradsen, J Henrichsen Acta Pædiatrica 80 (4), 423-427, 1991 | 113 | 1991 |
Quantity and avidity of pneumococcal antibodies before and up to five years after pneumococcal vaccination of elderly persons HB Konradsen Clinical infectious diseases 21 (3), 616-620, 1995 | 111 | 1995 |
Epidemiology of invasive pneumococcal infections in children aged 0–6 years in Denmark: a 19‐year nationwide surveillance study MS Kaltoft, N Zeuthen, HB Konradsen Acta Paediatrica 89, 3-10, 2000 | 110 | 2000 |
Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme ZB Harboe, P Valentiner-Branth, TL Benfield, JJ Christensen, ... Vaccine 28 (14), 2642-2647, 2010 | 106 | 2010 |
Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases H Cherif, O Landgren, HB Konradsen, M Kalin, M Björkholm Vaccine 24 (1), 75-81, 2006 | 99 | 2006 |
Variations in emm Type among Group A Streptococcal Isolates Causing Invasive or Noninvasive Infections in a Nationwide Study K Ekelund, J Darenberg, A Norrby-Teglund, S Hoffmann, D Bang, ... Journal of clinical microbiology 43 (7), 3101-3109, 2005 | 97 | 2005 |
Comparison of two urinary antigen tests for establishment of pneumococcal etiology of adult community-acquired pneumonia K Strålin, MS Kaltoft, HB Konradsen, P Olcén, H Holmberg Journal of Clinical Microbiology 42 (8), 3620-3625, 2004 | 97 | 2004 |
Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection HJ Lee, JH Kang, J Henrichsen, HB Konradsen, SH Jang, HY Shin, ... Vaccine 13 (16), 1533-1538, 1995 | 97 | 1995 |
An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study BD Plikaytis, D Goldblatt, CE Frasch, C Blondeau, MJ Bybel, GS Giebink, ... Journal of Clinical Microbiology 38 (6), 2043-2050, 2000 | 96 | 2000 |